IPO registrations (S-1, F-1) · Registrants
Lite Strategy, Inc.
- SEC CIK
- 1262104 · filings on EDGAR ↗
- Name on the registration
- MARSHALL EDWARDS INC
- Former names
- MEI Pharma, Inc. (2012–2025); MARSHALL EDWARDS INC (2003–2012)
- Registration
- Form S-1, first filed 2003-09-25, last 2012-03-20; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2003-12-18; declared effective 2006-09-05
- Industry (SIC)
- Finance Services 6199
- Incorporated in
- DE
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, San Diego, CA 92121
- EIN
- 51-0407811
- Ticker
- LITS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Lite Strategy, Inc. on the corporate pages
Offering terms
- Proposed price range
- $4.50–$6.50 per share (S-1/A filed 2003-12-10)
- Final price
- $9.00 per share, above the range (424B4 filed 2003-12-18, an initial public offering)
- Listing
- Nasdaq under the symbol MSHL
- Lead underwriters
- Janney Montgomery Scott
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: MEI PHARMA, INC EXACT (EIN (EXACT))
- Form D issuer: MEI Pharma, Inc. EXACT (CIK (EXACT))
- SEC filer: Lite Strategy, Inc. EXACT (CIK (EXACT))
- Person page: Charles Benjamin Lee Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 19
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-09-25 | S-1 | S-1 (registration) | MARSHALL EDWARDS INC | 0000950123-03-010789 ↗ |
| 2003-10-31 | S-1/A | S-1/A (amendment) | MARSHALL EDWARDS INC | 0000950123-03-012005 ↗ |
| 2003-11-26 | S-1/A | S-1/A (amendment) | MARSHALL EDWARDS INC | 0000950123-03-013228 ↗ |
| 2003-12-10 | S-1/A | S-1/A (amendment) | MARSHALL EDWARDS INC | 0000950123-03-013639 ↗ |
| 2003-12-18 | S-1MEF | S-1MEF (added securities) | MARSHALL EDWARDS INC | 0000950123-03-013918 ↗ |
| 2003-12-18 | 424B4 | 424B4 (final prospectus) | MARSHALL EDWARDS INC | 0000950123-03-013919 ↗ |
| 2006-09-05 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-06-001426 ↗ |
| 2007-10-19 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-07-004153 ↗ |
| 2008-04-03 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-08-000984 ↗ |
| 2011-03-07 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-11-000611 ↗ |
| 2011-05-26 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-11-001669 ↗ |
| 2011-08-15 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-11-002500 ↗ |
| 2012-02-21 | S-1 | S-1 (registration) | MARSHALL EDWARDS INC | 0001193125-12-068642 ↗ |
| 2012-03-20 | S-1/A | S-1/A (amendment) | MARSHALL EDWARDS INC | 0001193125-12-122620 ↗ |
| 2012-03-26 | EFFECT | EFFECT (declared effective) | MARSHALL EDWARDS INC | 9999999995-12-000834 ↗ |
| 2012-11-08 | EFFECT | EFFECT (declared effective) | MEI Pharma, Inc. | 9999999995-12-003197 ↗ |
| 2013-01-14 | EFFECT | EFFECT (declared effective) | MEI Pharma, Inc. | 9999999995-13-000178 ↗ |
| 2013-01-29 | EFFECT | EFFECT (declared effective) | MEI Pharma, Inc. | 9999999995-13-000318 ↗ |
| 2013-11-21 | EFFECT | EFFECT (declared effective) | MEI Pharma, Inc. | 9999999995-13-003334 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2003-12-10 | S-1/A | registration statement | $4.50–$6.50 | - | - | Nasdaq MSHL | 1 | primary document; range, cover names 1 | document ↗ | |
| 2003-12-18 | 424B4 | final prospectus | $9.00 | - | - | Nasdaq MSHL | 1 | primary document; price line, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Williams Bryan | Director | 5 | 2006–2012 | ||
| Rueckert William Dodge | Director | 19 | 2008–2019 | ||
| NAUGHTON CHRISTOPHER | Director,Officer | CEO & President | 1 | 2008 | |
| SEATON DAVID R | Officer | CFO & Secretary | 1 | 2008 | |
| NOVOGEN LTD | TenPercentOwner | 7 | 2008–2012 | ||
| JOHNSTON PHILIP A | Director | 1 | 2009 | ||
| GOLD DANIEL P PHD | Director; Director,Officer | Chief Executive Officer; President and Chief Executive | 26 | 2010–2023 | |
| Zech Thomas M. | Officer | Chief Financial Officer | 9 | 2010–2016 | |
| White Christine Anna | Director | 15 | 2010–2022 | ||
| Mass Robert D. | Officer | Chief Medical Officer | 15 | 2011–2020 | |
| Baltic Charles V. III | Director | 28 | 2011–2023 | ||
| Cann Leah Rush | Director | 8 | 2011–2016 | ||
| AUSTIN JOSIAH T | TenPercentOwner | 3 | 2012 | ||
| El Coronado Holdings, LLC | TenPercentOwner | 2 | 2012 | ||
| Vivo Ventures Fund VII, L.P. | TenPercentOwner | 6 | 2012–2013 | ||
| Vivo Ventures Fund V, L.P. | TenPercentOwner | 6 | 2012–2013 | ||
| Vivo Ventures V Affiliates Fund, L.P. | TenPercentOwner | 6 | 2012–2013 | ||
| Vivo Ventures VII Affiliates Fund, L.P. | TenPercentOwner | 6 | 2012–2013 | ||
| VIVO VENTURES VII, LLC | TenPercentOwner | 8 | 2012–2015 | ||
| Vivo Ventures V, LLC | TenPercentOwner | 8 | 2012–2015 | ||
| AKKARAJU SRINIVAS | TenPercentOwner | 2 | 2012–2013 | ||
| Chambon Philippe O. | TenPercentOwner | 7 | 2012–2015 | ||
| Delagardelle Jeani | TenPercentOwner | 7 | 2012–2015 | ||
| HUNT RONALD | TenPercentOwner | 7 | 2012–2015 | ||
| Lathi Vijay K | TenPercentOwner | 7 | 2012–2015 | ||
| New Leaf Venture Associates II, L.P. | TenPercentOwner | 7 | 2012–2015 | ||
| New Leaf Venture Management II, L.L.C. | TenPercentOwner | 7 | 2012–2015 | ||
| New Leaf Ventures II, L.P. | TenPercentOwner | 7 | 2012–2015 | ||
| NIEDEL JAMES | TenPercentOwner | 5 | 2012–2013 | ||
| Reynolds Thomas C | Director | 15 | 2013–2025 | ||
| Glover Nicholas | Director | 15 | 2013–2025 | ||
| Ratcliffe Liam | TenPercentOwner | 3 | 2013–2015 | ||
| Urso David M | Director,Officer; Officer | Chief Operating Officer & GC; President and CEO; Sr. V.P. and General Counsel; Sr. V.P. & General Counsel | 15 | 2014–2023 | |
| Clemens Kevan | Director | 9 | 2014–2021 | ||
| Drazba Brian G. | Officer | Chief Financial Officer | 10 | 2017–2022 | |
| DRISCOLL FREDERICK W | Director | 12 | 2018–2025 | ||
| HOWSON TAMAR D | Director | 6 | 2019–2023 | ||
| Cohen Cheryl | Director | 5 | 2020–2022 | ||
| GHALIE RICHARD G | Officer | Chief Medical Officer | 5 | 2021–2023 | |
| KANGO SUJAY | Director | 4 | 2021–2023 | ||
| Anson Advisors Inc. | TenPercentOwner | 5 | 2023 | ||
| Anson Funds Management LP | TenPercentOwner | 5 | 2023 | ||
| Anson Management GP LLC | TenPercentOwner | 5 | 2023 | ||
| Cable Car Capital LLC | TenPercentOwner | 5 | 2023 | ||
| Funicular Funds, LP | TenPercentOwner | 5 | 2023 | ||
| Kassam Moez | TenPercentOwner | 5 | 2023 | ||
| Ma-Weaver Jacob | TenPercentOwner | 5 | 2023 | ||
| Nathoo Amin | TenPercentOwner | 5 | 2023 | ||
| Winson Bruce Ross | TenPercentOwner | 5 | 2023 | ||
| File Justin J. | Director,Officer; Officer | CEO, CFO and Secretary; CFO and Corporate Secretary; Secretary, Acting CEO & CFO | 5 | 2023–2026 | |
| Flynn James P | Director | 10 | 2023–2026 | ||
| Datoo Taheer | Director | 1 | 2023 | ||
| Wood Steven D | Director | 5 | 2023–2025 | ||
| Lee Charles Benjamin | Director | 2 | 2025 | person page Fuzzy | |
| Riezman Joshua | Director | 3 | 2025 | ||
| Schornstein Alexander | TenPercentOwner | 2 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-05-30 | MEI Pharma, Inc. | Pharmaceuticals | $74,999,990 | $74,999,990 | 20 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | MEI Pharma, Inc. | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | Lite Strategy, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Lite Strategy, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MEI PHARMA, INC | EIN (EXACT) | ||
| Person page | Charles Benjamin Lee | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Finance Services, CA first:
- Marygold Companies, Inc. CA
- NATE'S FOOD CO. CA
- BLACKHAWK NETWORK HOLDINGS, INC CA
- Yueda Digital Holding CA
- SEQUOIA-LEGATO, INC CA
- PROSPER MARKETPLACE, INC CA
- FINCERA INC. CA
- FF EAI Robotics Ecosystem Inc. CA
- WEALTHFRONT CORP CA
- Oportun Financial Corp CA
In other datasets, the same topic (Finance) in CA:
- Lobbying client: A16Z CAPITAL MANAGEMENT FKA ANDREESSEN HOROWITZ (Federal lobbying (LDA))
Interests: Finance Services · Finance